Related references
Note: Only part of the references are listed.The rediscovery of platinum-based cancer therapy
Sven Rottenberg et al.
NATURE REVIEWS CANCER (2021)
Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Chemotherapy for resectable microsatellite instability-high gastric cancer?
Elizabeth C Smyth
LANCET ONCOLOGY (2020)
Analysis of clinicopathologic characteristics of gastric cancer in patients ≤40 and ≥40 years of age
Malgorzata Lawniczak et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)
Impact of Tumor Localization and Molecular Subtypes on the Prognostic and Predictive Significance of p53 Expression in Gastric Cancer
Bianca Grosser et al.
CANCERS (2020)
Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)
Avani Athauda et al.
EUROPEAN JOURNAL OF CANCER (2020)
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer
Bernhard Mlecnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Sex and gender: modifiers of health, disease, and medicine
Franck Mauvais-Jarvis et al.
LANCET (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer
Filippo Pietrantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability
Meike Kohlruss et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2019)
PD-L1 expression combined with microsatellite instability/CD8+tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer
Toshiaki Morihiro et al.
SCIENTIFIC REPORTS (2019)
Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology
Berna C. Ozdemir et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Fabio Conforti et al.
LANCET ONCOLOGY (2018)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
Protective Effects of Female Reproductive Factors on Lauren Intestinal-Type Gastric Adenocarcinoma
Su Mi Kim et al.
YONSEI MEDICAL JOURNAL (2018)
Prognostic value of differentiation status in gastric cancer
Fan Feng et al.
BMC CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches
Margherita Ratti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer
K. Polom et al.
BRITISH JOURNAL OF SURGERY (2018)
A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer
L. Bauer et al.
ANNALS OF ONCOLOGY (2018)
Danger signals: Chemotherapy enhancers?
Thaiz Rivera Vargas et al.
IMMUNOLOGICAL REVIEWS (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Mismatch Repair Deficiency, Microsatellite Instability, and Survival An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
Elizabeth C. Smyth et al.
JAMA ONCOLOGY (2017)
Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma Stage Adjusted Analysis From a Single High-volume Center in Asia
Hong Jae Chon et al.
ANNALS OF SURGERY (2017)
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients
Yuan Yuan et al.
CANCER CELL (2016)
The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients
Ming Lu et al.
MEDICINE (2016)
Sex differences in immune responses
Sabra L. Klein et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Differential DNA mismatch repair underlies mutation rate variation across the human genome
Fran Supek et al.
NATURE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
T. Schmidt et al.
BRITISH JOURNAL OF CANCER (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
The immuno-oncology framework Enabling a new era of cancer therapy
Axel Hoos et al.
ONCOIMMUNOLOGY (2012)
Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas A Summary of 480 Cases
Karen Becker et al.
ANNALS OF SURGERY (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Inclusion, Analysis, and Reporting of Sex and Race/Ethnicity in Clinical Trials: Have We Made Progress?
Stacie E. Geller et al.
JOURNAL OF WOMENS HEALTH (2011)
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials
P. Wheatley-Price et al.
ANNALS OF ONCOLOGY (2010)
A Multicenter Study to Validate the Reproducibility of MSI Testing With a Panel of 5 Quasimonomorphic Mononucleotide Repeats
Ermanno Nardon et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2010)
Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970-2006
Martin Rutegard et al.
EUROPEAN JOURNAL OF CANCER (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females
M. H. Derakhshan et al.
GUT (2009)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Development of a fluorescent multiplex assay for detection of MSI-high tumors
JW Bacher et al.
DISEASE MARKERS (2004)
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
H Elsaleh et al.
LANCET (2000)
Share Paper
